Organon (OGN) Prices $1B Notes Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/28/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Organon Announces Pricing of $1.0 Billion Senior Notes Offering
May 7, 2024 8:20 PM EDTJERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN) (Organon), a global healthcare company with a focus on womens health, announced today that it, together with Organon Foreign Debt Co-Issuer B.V., a direct wholly-owned subsidiary of Organon, as co-issuer (the Co-Issuer and, together with Organon, the Companies), have priced an offering of $500 million of 6.750% senior secured notes due 2034 (the Secured Notes) and $500 million of 7.875% senior unsecured notes due 2034 (the Unsecured Notes and, together with the Secured Notes the Notes). Each series of notes will be guaranteed by each of the entities that guarantees the Companies existing... More
